FDA Inspection
PTC Therapeutics, Inc.PTC Therapeutics, Inc. – FDA Inspection, Nov 18, 2024
Record Details
This FDA Inspection record concerns PTC Therapeutics, Inc., with an inspection on November 18, 2024, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · c448c3a3-8cc2-4787-a017-09ca7a7160e6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1254452
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring: Human Drugs
FDA Citations
1- 21 CFR 312.50General responsibilities of sponsors
Full citation text and observation details available on the Dashboard.
Other FDA inspections of PTC Therapeutics, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 22, 2025 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 12, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 8, 2017 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for PTC Therapeutics, Inc.
- FDA Inspection 1271557 - 2025-05-22
- FDA Inspection 1128908 - 2020-08-12
- FDA Inspection 1024973 - 2017-08-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.